Devices & Diagnostics

Urinary incontinence treatment firm testing device for fecal incontinence

A Minnesota urinary incontinence treatment company is now expanding to treat that other voiding dysfunction. Uroplasty (NASDAQ CM:UPI) announced Thursday that it is testing its Urgent PC Neuromodulation treatment for overactive bladders to now treat fecal incontinence. The company will launch a clinical trial in late summer in the U.S. The office-based, minimally invasive treatment is […]

Devices & Diagnostics

Overactive bladder treatment by Uroplasty wins new insurance reimbursement

Urinary incontinence products maker Uroplasty (NASDAQ:UPI) announced Monday that two private payers have agreed to cover its overactive bladder treatment. The Minnetonka, Minnesota-based urology firm has been winning coverage for its Urgent PC Neuromodulation treatment, which began with getting reimbursement from Medicare in November. And Wall Street has noticed. In the past year, the stock […]

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.